_{Publications:
Neuronal Convergence}

Mitricheva, E.; Kimura, R.; Logothetis, N.; Noori, H.: Reply to Poeppl et al.: Controlling for false positive rates is critical for accurate and consistent interpretation of findings. Proceedings of the National Academy of Sciences of the United States of America 117 (21), p. 11206 (2020)

Heinz, A.; Kiefer, F.; Smolka, M.; Endrass, T.; Beste, C.; Beck, A.; Liu, S.; Genauck , A.; Romund, L.; Banaschewski, T. et al.; Bermpohl, F.; Derserno, L.; Dolan, R.; Durstewitz, D.; Ebner-Priemer, U.; Flor, H.; Hansson, A.; Heim, C.; Hermann, D.; Kiebel, S.; Kirsch, P.; Kirschbaum, C.; Koppe, G.; Marxen, M.; Meyer-Lindenberg , A.; Nagel, W.; Noori, H.; Pilhatsch, M.; Priller, J.; Rietschel, M.; Romanczuk-Seiferth, N.; Schlagenhauf, F.; Sommer, W.; Stallkamp, J.; Ströhle, A.; Stock, A.; Winterer, G.; Winter, C.; Walter, H.; Witt, S.; Vollstädt-Klein, S.; Rapp, M.; Tost, H.; Spanagel, R.: Addiction Research Consortium: Losing and regaining control over drug intake (ReCoDe)-From trajectories to mechanisms and interventions. Addiction Biology 25 (2), pp. 1 - 6 (2020)

Egenrieder, L.; Mitricheva, E.; Spanagel, R.; Noori, H.: No basal or drug-induced sex differences in striatal dopaminergic levels: a cluster and meta-analysis of rat microdialysis studies. Journal of Neurochemistry 152 (4), pp. 482 - 492 (2020)

Noori, H.: Systemic neurochemical fingerprinting of clinically approved and experimental neuropsychiatric drugs: implications for pharmacotherapy of AUD. In 33rd European College of Neuropsychopharmacology Congress (ECNP 2020), S.02.03. 33rd European College of Neuropsychopharmacology Congress (ECNP 2020) , September 12, 2020 - September 15, 2020. (2020)